The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Zhejiang University
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Shanghai Yunying Medical Technology
Jules Bordet Institute
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Tarveda Therapeutics
SpeciCare
Royal Marsden NHS Foundation Trust
MultiVir, Inc.
Merrimack Pharmaceuticals
Optimata Ltd.
The University of Texas Health Science Center, Houston